Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: a phase 2 study from the GELTAMO group
Keywords:
Bendamustine
BEAM
Autologous stem-cell transplantation
Aggressive lymphomas
Clinical trial
Editorial note:
Copyright © 1999-2024 John Wiley & Sons, Inc or related companies. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
Citation:
Canales-Albendea, M. A. (Miguel Ángel); Redondo, A. M. (Alba M.); Valcarcel, D. (David); et al. "Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: a phase 2 study from the GELTAMO group". British Journal of Haematology. 184 (5), 2018, 797 - 807
Statistics and impact
0 citas en
0 citas en
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.